title: Response: upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.
authors.affiliation: a Division of Haematology , Ege University Medical Faculty Hospital, Department of Internal Medicine , Izmir , Turkey.
authors.forename: Güray
authors.initials: G
authors.lastname: Saydam
mesh_terms: D000970:Antineoplastic Agents; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D015466:Leukemia, Myeloid, Chronic-Phase; D011743:Pyrimidines
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines; D000068877:Imatinib Mesylate
keywords: Chronic myeloid leukemia; frontline treatment; nilotinib